Ignite Creation Date:
2024-07-17 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06465732
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-06-04
Brief Title:
Efficacy and Safety of Dupilumab in Combination With Tofacitinib in Moderate to Severe Adult AD Patients
Sponsor:
Second Affiliated Hospital School of Medicine Zhejiang University
Organization:
Second Affiliated Hospital School of Medicine Zhejiang University
Organization Data
Organization:
Second Affiliated Hospital School of Medicine Zhejiang University
Class:
OTHER
Study ID:
IR2024072
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Second Affiliated Hospital School of Medicine Zhejiang University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None